• Company
• Acetaminophen syrup receives price hikes to meet demand
• by Chon, Seung-Hyun Dec 28, 2023 06:02am

• Company
• Genexine completes trial on its long-acting anemia drug
• by Son, Hyung-Min Dec 28, 2023 06:02am

• Company
• KRW 250 bil market shakes from reimb reevaluations
• by Chon, Seung-Hyun Dec 28, 2023 06:02am

• Company
• Generic companies win 3 out 4 patent disputes
• by Kim, Jin-Gu Dec 27, 2023 11:39am

• Company
• Keytruda's indication expanded for early-stage lung cancer
• by Son, Hyung-Min Dec 27, 2023 06:05am

• Policy
• Reform should drive development of 2 homegrown blockbusters
• by Lee, Jeong-Hwan Dec 27, 2023 06:03am

• Company
• LegoChem licenses out ADC technology... a KRW 2.2 tril deal
• by Son, Hyung-Min Dec 27, 2023 06:03am

• Policy
• Swiss’s Idorsia applies for the reimb of its first product
• by Lee, Tak-Sun Dec 27, 2023 06:03am

• Company
• Reimbursed Leclaza nears annual sales of 1T won
• by Chon, Seung-Hyun Dec 26, 2023 01:11pm

• Company
• Restrictions on new AML drug Xospata may be lifted next yr
• by Eo, Yun-Ho Dec 26, 2023 05:47am